These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 34130940)
1. ANKS1A genotype predicts cardiovascular events in patients with familial hypercholesterolemia. Fantino M; Paquette M; Bernard S; Baass A J Clin Lipidol; 2021; 15(4):602-607. PubMed ID: 34130940 [TBL] [Abstract][Full Text] [Related]
2. The ZPR1 genotype predicts myocardial infarction in patients with familial hypercholesterolemia. Paquette M; Fantino M; Bernard S; Baass A J Clin Lipidol; 2020; 14(5):660-666. PubMed ID: 32807694 [TBL] [Abstract][Full Text] [Related]
3. Hemoglobin concentration, hematocrit and red blood cell count predict major adverse cardiovascular events in patients with familial hypercholesterolemia. Paquette M; Bernard S; Baass A Atherosclerosis; 2021 Oct; 335():41-46. PubMed ID: 34547589 [TBL] [Abstract][Full Text] [Related]
4. PHACTR1 genotype predicts coronary artery disease in patients with familial hypercholesterolemia. Paquette M; Dufour R; Baass A J Clin Lipidol; 2018; 12(4):966-971. PubMed ID: 29784573 [TBL] [Abstract][Full Text] [Related]
5. SLC22A3 is associated with lipoprotein (a) concentration and cardiovascular disease in familial hypercholesterolemia. Paquette M; Bernard S; Baass A Clin Biochem; 2019 Apr; 66():44-48. PubMed ID: 30772277 [TBL] [Abstract][Full Text] [Related]
6. Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia. Paquette M; Dufour R; Baass A Can J Cardiol; 2017 Oct; 33(10):1312-1318. PubMed ID: 28941610 [TBL] [Abstract][Full Text] [Related]
7. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia. Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300 [TBL] [Abstract][Full Text] [Related]
8. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study). Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165 [TBL] [Abstract][Full Text] [Related]
9. Paternal inheritance predicts earlier cardiovascular event onset in patients with familial hypercholesterolemia. Paquette M; Fantino M; Bernard S; Baass A Atherosclerosis; 2021 Jul; 329():9-13. PubMed ID: 34157652 [TBL] [Abstract][Full Text] [Related]
10. Familial Hypercholesterolemia Genetic Variations and Long-Term Cardiovascular Outcomes in Patients with Hypercholesterolemia Who Underwent Coronary Angiography. Lee WJ; Chuang HN; Chen YM; Liang KW; Tung H; Chen JP; Lee IT; Wang JS; Lin CH; Lin HJ; Sheu WH; Lee WL; Hsiao TH Genes (Basel); 2021 Sep; 12(9):. PubMed ID: 34573395 [TBL] [Abstract][Full Text] [Related]
11. Aortic Root Calcification Score as an Independent Factor for Predicting Major Adverse Cardiac Events in Familial Hypercholesterolemia. Okada H; Tada H; Hayashi K; Kawashima H; Takata T; Sakata K; Nohara A; Mabuchi H; Yamagishi M; Kawashiri MA J Atheroscler Thromb; 2018 Jul; 25(7):634-642. PubMed ID: 29321389 [TBL] [Abstract][Full Text] [Related]
12. LPA genotype is associated with premature cardiovascular disease in familial hypercholesterolemia. Paquette M; Bernard S; Thanassoulis G; Baass A J Clin Lipidol; 2019; 13(4):627-633.e1. PubMed ID: 31103339 [TBL] [Abstract][Full Text] [Related]
13. Effects of familial hypercholesterolemia-associated genes on the phenotype of premature myocardial infarction. Lee C; Cui Y; Song J; Li S; Zhang F; Wu M; Li L; Hu D; Chen H Lipids Health Dis; 2019 Apr; 18(1):95. PubMed ID: 30971288 [TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of familial hypercholesterolemia on long-term outcomes in patients undergoing percutaneous coronary intervention. Tscharre M; Herman R; Rohla M; Piackova E; Vargas KG; Farhan S; Freynhofer MK; Weiss TW; Huber K J Clin Lipidol; 2019; 13(1):115-122. PubMed ID: 30344049 [TBL] [Abstract][Full Text] [Related]
16. Systematic analysis of variants related to familial hypercholesterolemia in families with premature myocardial infarction. Brænne I; Kleinecke M; Reiz B; Graf E; Strom T; Wieland T; Fischer M; Kessler T; Hengstenberg C; Meitinger T; Erdmann J; Schunkert H Eur J Hum Genet; 2016 Feb; 24(2):191-7. PubMed ID: 26036859 [TBL] [Abstract][Full Text] [Related]
17. Long-term mipomersen treatment is associated with a reduction in cardiovascular events in patients with familial hypercholesterolemia. Duell PB; Santos RD; Kirwan BA; Witztum JL; Tsimikas S; Kastelein JJP J Clin Lipidol; 2016; 10(4):1011-1021. PubMed ID: 27578134 [TBL] [Abstract][Full Text] [Related]
18. Health related quality of life in individuals at high risk for familial hypercholesterolemia undergoing genetic cascade screening in Brazil. Souto AC; Miname MH; Fukushima J; Jannes CE; Krieger JE; Hagger M; Pereira AC; Santos RD Atherosclerosis; 2018 Oct; 277():464-469. PubMed ID: 30270086 [TBL] [Abstract][Full Text] [Related]
19. Novel combined variants of LDLR and LDLRAP1 genes causing severe familial hypercholesterolemia. Alnouri F; Athar M; Al-Allaf FA; Abduljaleel Z; Taher MM; Bouazzaoui A; Al Ammari D; Karrar H; Albabtain M Atherosclerosis; 2018 Oct; 277():425-433. PubMed ID: 30270081 [TBL] [Abstract][Full Text] [Related]
20. Familial hypercholesterolemia screening program in Bosnia and Herzegovina and cardiovascular morbidity. Pojskic L; Pojskic B Atherosclerosis; 2018 Oct; 277():278-281. PubMed ID: 30270059 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]